Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims

Long covid patients travel abroad for expensive and experimental “blood washing”

(2022) Madlen Davies   BMJ-British Medical Journal

Post-acute COVID-19 syndrome

(2021) Ani Nalbandian et al.   NATURE MEDICINE

The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions

(2021) Leigh Turner   Cell Stem Cell

Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic

(2021) Leigh Turner et al.   Stem Cell Reports

Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection

(2021) Destin Groff et al.   JAMA Network Open

Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19

(2020) Leigh Turner   Cell Stem Cell

Cell-Based Therapies for COVID-19: Proper Clinical Investigations are Essential

(2020) Maroun Khoury et al.   CYTOTHERAPY

Internet Searches for Unproven COVID-19 Therapies in the United States

(2020) Michael Liu et al.   JAMA Internal Medicine

Long-term Health Consequences of COVID-19

(2020) Carlos del Rio et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Unicorn Poo and Blessed Waters: COVID-19 Quackery and FDA Warning Letters

(2020) Katrina A. Bramstedt   Therapeutic Innovation & Regulatory Science

The coronavirus pandemic: a pitfall or a fast-track for validating cell therapy products?

(2020) maroun khoury et al.   STEM CELLS AND DEVELOPMENT

Marketing of unproven stem cell–based interventions: A call to action

(2017) Douglas Sipp et al.   Science Translational Medicine